Phenytoin overdose complicated by prolonged intoxication and residual neurological deficits

EMA - Emergency Medicine Australasia

Volumn 16, Issue 4, 2004, Pages 361-365

  Craig, Simon ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Activated charcoal; Overdose; Phenytoin; Poisoning; Toxicity

Indexed keywords

ACTIVATED CARBON; CEFTRIAXONE; DIAZEPAM; FLUCLOXACILLIN; GOLYTELY; METOCLOPRAMIDE; PHENYTOIN; SODIUM CHLORIDE; THIAMINE;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; CASE REPORT; CATHETER INFECTION; CEREBELLUM INJURY; CONSERVATIVE TREATMENT; DISEASE COURSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG OVERDOSE; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; HEMOPERFUSION; HOSPITAL DISCHARGE; HUMAN; INTESTINE LAVAGE; MALE; NEUROLOGICAL COMPLICATION; NEUROTOXICITY; PRIORITY JOURNAL; SEIZURE; SELF POISONING; SEPSIS; TREATMENT OUTCOME; UNCONSCIOUSNESS; VOMITING;

EID: 4143113422     PISSN: 17426731     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2004.00629.x     Document Type: Article

References (21)

1. Larsen JR, Larsen LS. Clinical features and management of poisoning due to phenytoin. Med. Toxicol. Adverse Drug Exp. 1989; 4: 229-45.
2. Seger D, Phenytoin and Other Anticonvulsants. In: Haddad L, Winchester J, eds. Clinical Management of Poisoning and Drug Overdose, 2nd edn. Philadelphia: WB Saunders, 1990; 877-84.
3. Brandolese R, Scordo MG, Spina E, Gusella M, Padrini R. Severe phenytoin intoxication in a subject homozygous for CYP2C9*3. Clin. Pharmacol. Ther. 2001; 70: 391-4.
4. Osborn H. Phenytoin and Fosphenytoin Toxicity. In: Tintinalli JE, Kelen GD, Stapczynski JS, eds. Emergency Medicine: A Comprehensive Study Guide, 6th edn. New York: McGraw Hill, 2004; 1117-21.
5. Alioglu Z, Sari A, Velioglu SK, Ozmenoglu M. Cerebellar atrophy following acute phenytoin intoxication. J. Neuroradiol. 2000; 27: 52-5.
6. Weichbrodt GD, Elliott DP. Treatment of phenytoin toxicity with repeated doses of activated charcoal. Ann. Emerg. Med. 1987; 16: 1387-9.
7. Dolgin JG, Nix DE, Sanchez J, Watson WA. Pharmacokinetic simulation of the effect of multiple-dose activated charcoal in phenytoin poisoning - report of two paediatric cases. DICP 1991; 25: 646-9.
8. Howard CE, Roberts RS, Ely DS, Moye RA. Use of multiple-dose activated charcoal in phenytoin toxicity. Ann. Pharmacother. 1994; 28: 201-3.
9. Ros S, Black L. Multiple-dose activated charcoal in management of phenytoin overdose. Paediatr. Emerg. Care 1989; 5: 169-70.
10. Rowden AM, Spoor JE, Bertino JS Jr. The effect of activated charcoal on phenytoin pharmacokinetics. Ann. Emerg Med. 1990; 19: 1144-7.
11. Mauro LS, Mauro VF, Brown DL, Somani P. Enhancement of phenytoin elimination by multiple-dose activated charcoal. Ann. Emerg. Med. 1987; 16: 1132-5.
12. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement and practice guidelines on the use of multiple-dose activated charcoal in the treatment of acute poisoning. J. Toxicol. Clin. Toxicol. 1999; 37: 731-51.
13. Kawasaki C, Nishi R, Uekihara S, Hayono S, Otagiri M. Charcoal haemoperfusion in the treatment of phenytoin overdose. Am. J. Kidney Dis. 2000; 25: 323-6.
14. Kanayama Y, Itakura Y, Iwasaki M et al. Changes in phenytoin concentrations in blood and cerebrospinal fluid caused by direct haemoperfusion in a patient intoxicated with phenytoin. Ther. Apher. 1998; 2: 74-7.
15. Baehler RW, Work J, Smith W, Dominic JA. Charcoal hemoperfusion in the therapy for methsuximide and phenytoin overdose. Arch. Intern. Med. 1980; 140: 1466-8.
16. Larsen LS, Sterrett JR, Whitehead B, Marcus SM. Adjunctinve therapy of phenytoin overdose - a case report using plasmapharesis. J. Toxicol. Clin. Toxicol. 1986; 24: 37-49.
17. White RL, Garnett WR, Allen JH. Phenytoin removal during plasma exchange. J. Clin. Apheresis 1987; 3: 147-50.
18. Adler DS, Martin E, Gambertoglio JG, Tozer TN, Spire JP. Haemodialysis of phenytoin in a uraemic patient. Clin. Pharmacol. Ther. 1975; 18: 65-9.
19. Dasgupta A, Abu-Alfa A. Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uraemia treated with haemodialysis: role of uraemic compounds. Am. J. Clin. Pathol 1992; 98: 19-25.
20. Frenchie D, Bastani B. Significant removal of phenytoin during high flux dialysis with cellulose triacetate dialyzer. Nephrol. Dial. Transplant. 1998; 13: 817-18.
21. Sen S, Ratnaraj N, Davies N et al. Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia 2003; 44: 265-7.